Juan Pablo Alzate Granados

Dr. Juan Pablo Alzate Granados


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
MGMaría F. Garcés
María F. Garcés
JPJhon J. Peralta
Jhon J. Peralta
CRCarlos E. Ruiz-Linares
Carlos E. Ruiz-Linares
ALAna R. Lozano
Ana R. Lozano
NPNatalia E. Poveda
Natalia E. Poveda
JCJorge E. Caminos
Jorge E. Caminos
Irisin is a recently discovered adipomyokine that regulates the differentiation and phenotype of adipose tissue. In this study, we investigated the levels of irisin over the three trimesters of gestation in healthy and preeclamptic women and during the follicular and luteal phase of the menstrual cycle in a cohort of healthy eumenoherric women. Serum irisin was measured by an ELISA in a longitudinal prospective cohort study in 40 healthy pregnant women, 10 mild preeclamptic women, and 20 healthy eumenoherric women during the menstrual cycle to assess irisin levels and correlations with other metabolic parameters. We identified the protein expression of fibronectin type III domain-containing protein 5, the irisin precursor, in human placenta using immunohistochemical approaches in humans. Serum irisin levels are higher in the luteal than in the follicular phase in eumenorrheic women. Fibronectin type III domain-containing protein 5, the irisin precursor, is expressed in human placenta, and its serum levels are higher during the entire pregnancy when compared with nonpregnant women. Serum irisin correlates positively with the homeostasis model assessment of estimated insulin resistance in the first trimester of normal pregnancy. Serum irisin levels do not change throughout gestation in preeclamptic women; however, there were lower irisin levels during the third trimester when compared with the normal pregnant group. Our results suggest that irisin may be involved in reproductive function and in the pregnancy-associated metabolic changes, and this condition may be an irisin-resistant state during gestation.

17 January 2014 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
MGMaría F Garcés
María F Garcés
ESElizabeth Sanchez
Elizabeth Sanchez
ATAlejandra L Torres-Sierra
Alejandra L Torres-Sierra
ARAriel I Ruíz-Parra
Ariel I Ruíz-Parra
EAEdith Angel-Müller
Edith Angel-Müller
JCJorge Caminos
Jorge Caminos

3 October 2017 in Health Policy and Planning
Verified
Journal Article
Open access
PDF file
JEJavier Eslava-Schmalbach
Javier Eslava-Schmalbach
PMPaola Mosquera
Paola Mosquera
JGJuan Pablo Alzate Granados
Juan Pablo Alzate Granados
KPKevin Pottie
Kevin Pottie
VWVivian Welch
Vivian Welch
PTPeter Tugwell
Peter Tugwell
The availability of evidence-based guidelines does not ensure their implementation and use in clinical practice or policy making. Inequities in health have been defined as those inequalities within or between populations that are avoidable, unnecessary and also unjust and unfair. Evidence-based clinical practice and public health guidelines (‘guidelines’) can be used to target health inequities experienced by disadvantaged populations, although guidelines may unintentionally increase health inequities. For this reason, there is a need for evidence-based clinical practice and public health guidelines to intentionally target health inequities experienced by disadvantaged populations. Current guideline development processes do not include steps for planned implementation of equity-focused guidelines. This article describes nine steps that provide guidance for consideration of equity during guideline implementation. A critical appraisal of the literature followed by a process to build expert consensus was undertaken to define how to include consideration of equity issues during the specific GRADE guideline development process. Using a case study from Colombia we describe nine steps that were used to implement equity-focused GRADE recommendations: (1) identification of disadvantaged groups, (2) quantification of current health inequities, (3) development of equity-sensitive recommendations, (4) identification of key actors for implementation of equity-focused recommendations, (5) identification of barriers and facilitators to the implementation of equity-focused recommendations, (6) development of an equity strategy to be included in the implementation plan, (7) assessment of resources and incentives, (8) development of a communication strategy to support an equity focus and (9) development of monitoring and evaluation strategies. This case study can be used as model for implementing clinical practice guidelines, taking into account equity issues during guideline development and implementation.

29 August 2019 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
JSJose Daniel Suarez‐Torres
Jose Daniel Suarez‐Torres
JGJuan Pablo Alzate Granados
Juan Pablo Alzate Granados
MOMaria Erley Orjuela‐Ramirez
Maria Erley Orjuela‐Ramirez

30 March 2024 in Pathology - Research and Practice
Verified
Journal Article
Closed access
RPRafael Parra-Medina
Rafael Parra-Medina
JCJuan Pablo Castañeda-González
Juan Pablo Castañeda-González
VCViviana Chaves-Cabezas
Viviana Chaves-Cabezas
JGJuan Pablo Alzate Granados
Juan Pablo Alzate Granados
JCJuan Jose Chaves Cabezas
Juan Jose Chaves Cabezas

6 December 2019 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
NPNataly Portilla
Nataly Portilla
JGJuan Pablo Alzate Granados
Juan Pablo Alzate Granados
FSFabio A. Sierra
Fabio A. Sierra
RPRafael Parra-Medina
Rafael Parra-Medina